Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Mar 23, 2021 10:11am
212 Views
Post# 32857436

RE:RDW Insider Buying

RE:RDW Insider Buying
99942Apophis wrote: I just checked and RDW hasn't bought this month! Question is he buys mostly in the later part of the month so he may still do so or he might be aware of material news! My wild guess is it is because of material news. We are all expecting more patients to be treated and new clinical sites to be added to our growing list as the population in Canada and US are vaccinated.  I recall that (TLT) stating they were in the hope of reaching the target of 25 by early 2021 but I honestly don't know if that is first quarter or first half. Wishes and dreams its before the end of April. 


Yeah it is all in the data isn't it? Just patiently waiting for those CR %s to spike. My guess now is we see that big spike late this year, early next year.

Those that have waited patiently will then see a buyout, or at least a spike in SP that will lead to a NORMAL financing.

<< Previous
Bullboard Posts
Next >>